Related Experiment Video

Updated: Aug 17, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

Selective afterload reduction in the treatment of septal rupture complicating myocardial infarction. A case report

R P Friedlander, M J Schwartz

    Cardiology
    |January 1, 1980
    PubMed

    Insights

    Hydralazine can reduce shunting in ventricular septal defects after myocardial infarction. This drug improved the left-to-right shunt ratio in a patient, though they ultimately died before surgery.

    Area of Science:

    • Cardiology
    • Cardiovascular Surgery

    Background:

    • Interventricular septal rupture is a rare but often fatal complication of acute myocardial infarction.
    • Successful surgical repair typically requires delayed intervention until myocardial healing occurs.

    Observation:

    • A case study investigated the use of hydralazine in a patient with acute myocardial infarction complicated by ventricular septal rupture.
    • Hydralazine, a selective peripheral vasodilator, was administered to manage the condition.

    Findings:

    • The administration of hydralazine led to a significant reduction in the left-to-right shunt ratio across the ventricular septal defect.
    • Despite this hemodynamic improvement, the patient did not survive to undergo surgical repair.

    Implications:

    • Hydralazine may serve as a temporizing medical therapy to improve hemodynamic stability in patients with acute myocardial infarction and ventricular septal rupture.
    • This approach could potentially facilitate delayed surgical intervention by reducing shunt severity and improving patient condition.

    More Related Videos

    Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy07:02

    Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

    Published on: September 9, 2020

    Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment08:49

    Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

    Published on: August 2, 2024

    Related Concept Videos

    Aortic Regurgitation III: Medical Management01:25

    Aortic Regurgitation III: Medical Management

    Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

    Cardiomyopathy VII: Pre and Post Operative Nursing Management

    Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...